We came across a bullish thesis on Bausch Health Companies Inc. on Countervail Capital’s Substack by Johann Colloredo-Mansfeld. In this article, we will summarize the bulls’ thesis on BHC. Bausch Health Companies Inc.'s share was trading at $7.25 as of September 11th. BHC’s trailing and forward P/E were 27.88 and 1.76 respectively according to Yahoo Finance.
[caption id="attachment_570725" align="aligncenter" width="750"]Bausch Health (BHC), formerly Valeant Pharmaceuticals, is a diversified healthcare company spanning...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.